Lugovskoy E V, Gritsenko P G, Kapustianenko L G, Kolesnikova I N, Chernishov V I, Komisarenko S V
Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
FEBS J. 2007 Sep;274(17):4540-9. doi: 10.1111/j.1742-4658.2007.05983.x. Epub 2007 Aug 6.
Four mAbs of the IgG(1) class to the thrombin-treated N-terminal disulfide knot of fibrin, secreted by various hybridomas, have been selected. Epitopes for two mAbs, I-3C and III-10d, were situated in human fibrin fragment Bbeta15-26, and those for two other mAbs, I-5G and I-3B, were in fragment Bbeta26-36. Three of these mAbs, I-5G, I-3B and III-10D, as well as their Fab-fragments, decreased the maximum rate of fibrin desAA and desAABB polymerization up to 90-95% at a molar ratio of mAb (or Fab-fragment) to fibrin of 1 or 2. The fourth mAb, I-3C, did not influence the fibrin desAABB polymerization and inhibited by 50% the maximum rate of fibrin desAA polymerization. These results suggest that these mAb inhibitors block a longitudinal fibrin polymerization site. As the mAbs retard both fibrin desAABB and fibrin desAA polymerization, one can conclude that the polymerization site does not coincide with polymerization site 'B' (Bbeta15-17). To verify this suggestion, the polymerization inhibitory activity of synthetic peptides BbetaSARGHRPLDKKREEA(12-26), BbetaLDKKREEA(19-26), BbetaAPSLRPAPPPI(26-36), BbetaAPSLRPAPPPISGGGYRARPA(26-46) and BbetaGYRARPA(40-46), which imitate the various sequences in the N-terminal region of the fibrin Bbeta-chain, have been investigated. Peptides Bbeta12-26 and Bbeta26-46, but not Bbeta40-46, Bbeta19-26, and Bbeta26-36, proved to be specific inhibitors of fibrin polymerization. The IC(50) values for Bbeta12-26 and Bbeta26-46 were 2.03 x 10(-4) and 2.19 x 10(-4) m, respectively. Turbidity and electron microscopy data showed that peptides Bbeta12-26 and Bbeta26-46 inhibited the fibrin protofibril formation stage of fibrin polymerization. The conclusion was drawn that fibrin fragment Bbeta12-46 took part in fibrin protofibril formation simultaneously with site 'A' (Aalpha17-19) prior to removal of fibrinopeptide B. A model of the intermolecular connection between fragment Bbeta12-46 of one fibrin desAA molecule and the D-domain of another has been constructed.
已筛选出由多种杂交瘤分泌的4种IgG(1)类单克隆抗体,它们作用于经凝血酶处理的纤维蛋白N端二硫键纽结。两种单克隆抗体I-3C和III-10d的表位位于人纤维蛋白片段Bβ15 - 26,另外两种单克隆抗体I-5G和I-3B的表位位于片段Bβ26 - 36。其中3种单克隆抗体I-5G、I-3B和III-10D及其Fab片段,在单克隆抗体(或Fab片段)与纤维蛋白的摩尔比为1或2时,可将纤维蛋白desAA和desAABB聚合的最大速率降低达90 - 95%。第4种单克隆抗体I-3C不影响纤维蛋白desAABB聚合,对纤维蛋白desAA聚合的最大速率有50%的抑制作用。这些结果表明这些单克隆抗体抑制剂阻断了纤维蛋白纵向聚合位点。由于这些单克隆抗体同时延缓了纤维蛋白desAABB和纤维蛋白desAA的聚合,因此可以得出结论,聚合位点与聚合位点“B”(Bβ15 - 17)不一致。为验证这一推测,研究了模拟纤维蛋白Bβ链N端区域不同序列的合成肽BβSARGHRPLDKKREEA(12 - 26)、BβLDKKREEA(19 - 26)、BβAPSLRPAPPPI(26 - 36)、BβAPSLRPAPPPISGGGYRARPA(26 - 46)和BβGYRARPA(40 - 46)对纤维蛋白聚合的抑制活性。结果证明,肽Bβ12 - 26和Bβ26 - 46是纤维蛋白聚合的特异性抑制剂,而Bβ40 - 46、Bβ19 - 26和Bβ26 - 36不是。Bβ12 - 26和Bβ26 - 46的IC(50)值分别为2.03×10(-4)和2.